Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Corcept Therapeutics (NASDAQ: CORT) has announced it will release its third quarter financial results and provide a corporate update on October 30, 2024. The company will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on the same day. Participants must pre-register to receive dial-in details and a unique access PIN. A listen-only webcast option will also be available, with a replay accessible through the company's website.
Corcept Therapeutics (NASDAQ: CORT) ha annunciato che rilascerà i propri risultati finanziari del terzo trimestre e fornirà un aggiornamento aziendale il 30 ottobre 2024. L'azienda ospiterà una conferenza telefonica alle 17:00 ora orientale (14:00 ora del Pacifico) lo stesso giorno. I partecipanti devono registrarsi in anticipo per ricevere i dettagli di accesso e un codice PIN unico. Sarà disponibile anche un'opzione di webcast in ascolto solo, con una registrazione accessibile attraverso il sito web dell'azienda.
Corcept Therapeutics (NASDAQ: CORT) ha anunciado que publicará sus resultados financieros del tercer trimestre y proporcionará una actualización corporativa el 30 de octubre de 2024. La empresa organizará una conferencia telefónica a las 5:00 p.m. hora del este (2:00 p.m. hora del Pacífico) el mismo día. Los participantes deben registrarse con anticipación para recibir los detalles de conexión y un PIN de acceso único. También estará disponible una opción de transmisión de solo escucha, con una repetición accesible a través del sitio web de la empresa.
Corcept Therapeutics (NASDAQ: CORT)는 2024년 10월 30일에 3분기 재무 결과를 발표하고 회사 업데이트를 제공할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 5시(태평양 표준시 오후 2시)에 전화 회의를 개최할 예정입니다. 참가자는 접속 정보와 고유한 액세스 PIN을 받기 위해 사전 등록해야 합니다. 청취 전용 웹캐스트 옵션도 제공되며, 회사 웹사이트를 통해 재생할 수 있습니다.
Corcept Therapeutics (NASDAQ: CORT) a annoncé qu'il publiera ses résultats financiers du troisième trimestre et fournira une mise à jour d'entreprise le 30 octobre 2024. L'entreprise organisera une téléconférence à 17h00, heure de l'Est (14h00, heure du Pacifique) le même jour. Les participants doivent s'inscrire à l'avance pour recevoir les détails de connexion et un code PIN d'accès unique. Une option de webinaire en écoute seule sera également disponible, avec une rediffusion accessible via le site Web de l'entreprise.
Corcept Therapeutics (NASDAQ: CORT) hat bekannt gegeben, dass es seine Finanzergebnisse für das dritte Quartal veröffentlichen und ein Unternehmens-Update am 30. Oktober 2024 bereitstellen wird. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time (14:00 Uhr Pazifikszeit) eine Telefonkonferenz abhalten. Teilnehmer müssen sich im Voraus registrieren, um Zugriffsdaten und eine einzigartige Zugangs-PIN zu erhalten. Es wird auch eine nur hörbare Webcast-Option verfügbar sein, mit einer Wiederholung, die über die Website des Unternehmens zugänglich ist.
- None.
- None.
Conference Call Information
Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number, and a unique access PIN. Each access PIN will accommodate one caller.
Additionally, a listen-only webcast will be available by clicking here.
A replay of the call will be available on the Investors / Events tab of Corcept.com.
About Corcept Therapeutics
For over 25 years, Corcept’s focus on cortisol modulation and its potential to treat patients with a wide variety of serious disorders has led to the discovery of more than 1,000 proprietary selective cortisol modulators. Corcept is conducting advanced clinical trials in patients with hypercortisolism, solid tumors, amyotrophic lateral sclerosis (ALS) and liver disease. In February 2012, the company introduced Korlym®, the first medication approved by the
View source version on businesswire.com: https://www.businesswire.com/news/home/20241023550946/en/
Investor inquiries:
ir@corcept.com
Media inquiries:
communications@corcept.com
www.corcept.com
Source: Corcept Therapeutics Incorporated
FAQ
When will Corcept Therapeutics (CORT) report Q3 2024 earnings?
What time is Corcept Therapeutics (CORT) Q3 2024 earnings call?
How can I access Corcept Therapeutics (CORT) Q3 2024 earnings call?
